This winter's brutal flu season isn't over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, ...

A Phase 2 trial is testing a weekly intranasal spray that primes early immune defenses to reduce respiratory virus illness. The virus-agnostic approach targets multiple pathogens rather than a single ...